Awaiting development: Guidance and quality standards

Showing 281 to 290 of 332

Guidance and quality standards awaiting development
Title	Type
Speedboat Inject for endoscopic submucosal dissection of lower gastrointestinal lesions	Health technology evaluation
Staged bilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor	Interventional procedures guidance
STG320 for treating allergic rhinitis or rhinoconjunctivitis caused by house dust mites [ID1278]	Technology appraisal guidance
STS101 for treating acute migraine [TSID11782]	Technology appraisal guidance
Subcutaneous efgartigmod with recombinant human hyaluronidase PH20 for treating primary immune thrombocytopenia [TSID11977]	Technology appraisal guidance
Subcutaneous mosunetuzumab for treating relapsed or refractory follicular lymphoma after 2 or more treatments TSID 12081	Technology appraisal guidance
Supporting independent living and preventing isolation in adults of working age with social care needs	Quality standard
Talazoparib with enzalutamide for untreated hormone-sensitive metastatic prostate cancer with a homologous recombination repair mutation [ID6460]	Technology appraisal guidance
Tasimelteon for treating sleep disturbance associated with Smith-Magenis syndrome [TSID12191]	Technology appraisal guidance
Technologies to support home monitoring of vision change in macular disease	Health technology evaluation